Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Scynexis
Biotech
Ayala, Advaxis merger means new leadership team—Chutes & Ladders
Ayala sheds execs amid merger; Scynexis CEO leaves in C-suite shake-up; Mirror Biologics taps Scott Filosi to lead.
Gabrielle Masson
,
Max Bayer
Oct 21, 2022 9:30am
Scynexis' new antifungal delivers in yeast infection phase 3
Apr 21, 2020 10:00am
Merck scouting for CEO replacements—Chutes & Ladders
Jun 21, 2019 9:30am
Ex- Medicines Company executive lands at Scynexis
Jun 17, 2019 8:25am
First phase 3 data back Scynexis' new-class antifungal
Jan 31, 2019 10:51am
Scynexis’ new antifungal heads to phase 3
Jul 11, 2018 9:30am